INS and metabolic syndrome: Insulin resistance is likely established in an individual for several years before hyperglycemia develops [40], hence, indices of glucose tolerance, insulin sensitivity, and β-cell function are valid measurements to assess risk of metabolic diseases, such as type 2 diabetes and MetS.